Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Acridine Orange hydrochloride (AC114)
Cat.#: ASSD-114
Specifications
Description Acridine Orange hydrochloride is a cell-permeable fluorescent nucleic acid binding dye. It binds to both RNA and DNA producing fluorescence in a variety of colors. Inhibits mitosis. Displays anticancer properties under photon energy. Synonyms Rhoduline Orange Size 50 mg Chemical Name 3,6-Bis(dimethylamino)acridine hydrochloride Molecule Weight 301.81 Molecular formula C17H19N3.HCl CAS Number 65-61-2 PubChem identifier 517204 Purity >98% Solubility Souble in water (100mM) and DMSO (100mM) Form Red solid Storage RT Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-101 Cresyl Violet Solution (1%) (AC101) 250 mL, 500 mL, inquiry ASSD-126 Fluorescent H2 antagonist [aminopotentidine] (AC126) 50 μg inquiry ASSD-195 6-Aminofluorescein (AC195) 1 g inquiry ASSD-172 Ionomycin free acid (AC172) 1mg, 5mg inquiry ASSD-179 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) 1 mg, 5 mg inquiry ASSD-147 Rhodamine phalloidin-TRITC (AC147) 300 tests, 100μg inquiry ASSD-221 Antifade Fluorescence Mounting Medium with DAPI (hard set) (AC221) 10 mL inquiry ASSD-171 Ionomycin calcium salt (AC171) 1mg, 5mg inquiry ASSD-110 Picro Sirius Red Stain Kit (AC110) 1 kit, 100 tests inquiry ASSD-177 Fluorescein 5-Maleimide (AC177) 25 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket